secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001213900-24-004491
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare appoints Michael Sardano to Board of Directors effective Feb 1, 2024
--------------------------------------------------------------------------------

- Michael Sardano, currently President, General Counsel, and Corporate Secretary, appointed as Class II director.
- Term expires at the 2026 annual meeting; no committee assignments.
- Mr. Sardano is the son of Chairman and CEO Joseph C. Sardano.
- No arrangement or understanding with any other person led to the appointment.
- He has been employed by the Company since 2013 in various legal and management roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024004491/0001213900-24-004491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024004491/ea191731-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-004491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer